Skip to content
★ Sign in to follow
CP

CURAXIS PHARMACEUTICAL Corp Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by GEORGE MICHAEL W, was filed 12 Oct 2011.

CURAXIS PHARMACEUTICAL Corp: what insiders have been doing

CURAXIS PHARMACEUTICAL Corp is a listed company. Filings by its managers are published through SEC (Form 4). No insider at CURAXIS PHARMACEUTICAL Corp has published a filing in the past twelve months. The most recent one dates from 24 January 2012.

Over the whole record (from 2011), the tally stands at 4 purchases and 7 sales.

These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
19
Thresholds
n/a
Buy Volume
€14,198
4 ops. · all time
Sell Volume
€279,858
7 ops. · all time
Last declaration on 24 January 2012
Declarations19 total
  • ◆
    DirectorExecutives
    8,000 USD0SEC
    200,000 shares@ US$0.04Common StockSEC:0001354488-12-000261:0
  • ◆
    DirectorExecutives
    6,000 USD0SEC
    150,000 shares@ US$0.04Common StockSEC:0001354488-12-000257:0
  • ◆
    DirectorExecutives
    4,670 USD0SEC
    55,000 shares@ US$0.0849Common StockSEC:0001354488-11-004626:0
  • ◆
    DirectorExecutives
    3,331 USD0SEC
    39,229 shares@ US$0.0849Common StockSEC:0001354488-11-004626:1
  • ◆
    DirectorExecutives
    8,000 USD0SEC
    94,229 shares@ US$0.0849Common StockSEC:0001354488-11-004624:0
  • ◆
    DirectorExecutives
    6,000 USD0SEC
    70,671 shares@ US$0.0849Common StockSEC:0001354488-11-004622:0
  • ▼
    10% OwnerExecutives
    82,500 USD0SEC
    1,650,000 shares@ US$0.05Common StockSEC:0001354488-11-004050:0
  • ●
    Vice President - FinanceExecutives
    0SEC
    25,000 shares0Common StockSEC:0001354488-11-003754:0
  • ▲
    DirectorExecutives
    5,000 USD0SEC
    100,000 shares@ US$0.05Common StockSEC:0001354488-11-003750:0
    Canonical exit: 8 Jan 2012 (T+90)
  • ▼
    10% OwnerExecutives
    41,000 USD0SEC
    820,000 shares@ US$0.05Common StockSEC:0001354488-11-003752:0
  • ●
    10% OwnerExecutives
    0SEC
    25,000 shares0Common StockSEC:0001354488-11-003752:1
  • ▲
    DirectorExecutives
    0SEC
    50,000 shares0Common StockSEC:0001354488-11-003686:0
    Canonical exit: 1 Jan 2012 (T+90)
  • ▼
    10% OwnerExecutives
    97,000 USD0SEC
    1,000,000 shares@ US$0.097Common StockSEC:0001354488-11-003688:0
  • ▼
    10% OwnerExecutives
    5,100 USD0SEC
    150,000 shares@ US$0.034Common StockSEC:0001354488-11-003688:1
  • ▼
    10% OwnerExecutives
    45,000 USD0SEC
    900,000 shares@ US$0.05Common StockSEC:0001354488-11-003688:2
  • ▲
    DirectorExecutives
    5,000 USD0SEC
    100,000 shares@ US$0.05Common StockSEC:0001354488-11-003493:0
    Canonical exit: 15 Dec 2011 (T+90)
  • ▼
    10% OwnerExecutives
    77,500 USD0SEC
    1,550,000 shares@ US$0.05Common StockSEC:0001354488-11-002952:0
  • ▼
    10% OwnerExecutives
    35,000 USD0SEC
    350,000 shares@ US$0.10Common StockSEC:0001354488-11-002952:1
  • ▲
    DirectorExecutives
    10,000 USD0SEC
    200,000 shares@ US$0.05Common StockSEC:0001354488-11-002805:0
    Canonical exit: 13 Nov 2011 (T+90)

19 of 19 declarations

About CURAXIS PHARMACEUTICAL Corp

CURAXIS PHARMACEUTICAL Corp is a company focused on developing innovative treatments for neurological disorders. It is listed on the NASDAQ.